Pictet Asset Management Holding Sa Madrigal Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 208,484 shares of MDGL stock, worth $70.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
208,484
Previous 150,598
38.44%
Holding current value
$70.1 Million
Previous $32 Million
101.29%
% of portfolio
0.07%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$743 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$687 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$682 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$670 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$664 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.75B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...